Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06173999
PHASE1/PHASE2

A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

View on ClinicalTrials.gov

Summary

The study is being conducted to evaluate the safety and efficacy of SHR2554 with CHOP/CHOEP in treatment- naïve peripheral T-cell lymphoma.

Official title: A Phase Ib/II, Open-label, Multi-center Study of SHR2554 With CHOP/CHOEP in Treatment-naïve Patients With Peripheral T-cell Lymphoma

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-12-22

Completion Date

2025-12-31

Last Updated

2024-05-14

Healthy Volunteers

No

Interventions

DRUG

SHR2554/CHOP

SHR2554 with CHOP

DRUG

SHR2554/CHOEP

SHR2554 with CHOEP

Locations (1)

Beijing Cancer Hospital

Beijing, Beijing Municipality, China